Ambry Genetics Corporation
Aliso Viejo, CA Doing business as Konica Minolta Healthcare Americas, Inc., Wayne, NJ Part of Tempus AI, Inc.
- UEI
- E1VBXEM76NC5
- CAGE
- 515T2
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Tempus AI, Inc., ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Tempus AI, Inc. · Chicago, IL
PW4TQZ3KDLU3
-
- Aliso Viejo, CA F3HJHYFMNR48
-
-
Parent
Tempus AI, Inc. · Chicago, IL
PW4TQZ3KDLU3
- SAM.gov registration date
- Physical address
- 1 Enterprise, Aliso Viejo, CA 92656, USA
- Website
- ambrygen.com
- Founded
- 1999
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$404,472 |
| FY2025 | $16,050 |
| FY2024 | $15,828 |
| FY2023 | -$297,989 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| University Of California Irvine | U01HG011745 | $253,800 | |
| University Of California Irvine | U01HG011745 | $460,000 | |
| University Of California Irvine | U01HG011745 | $218,750 | |
| University Of California Irvine | U01HG011745 | $218,750 | |
| University Of California Irvine | U01HG011745 | $35,652 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Natera Inc. | Austin, TX | 621511 Medical Laboratories |
| Prevention Genetics | Marshfield, WI | 621511 Medical Laboratories |
| Veracyte, Inc. | South San Francisco, CA | 621511 Medical Laboratories |
| Baylor Miraca Genetics Laboratories LLC | Houston, TX | 621511 Medical Laboratories |
| Neogenomics Laboratories, Inc. | Fort Myers, FL | 541380 Testing Laboratories and Services |
About the company
Ambry Genetics Corporation, doing business as Konica Minolta Healthcare Americas, Inc., operates as a specialized genetic and molecular laboratory testing provider delivering cancer predisposition panels, whole genome sequencing, and variant confirmation services to federal healthcare agencies as a prime contractor on delivery orders and indefinite delivery contracts, with no small business set-asides across its federal footprint. The company is a subsidiary of Tempus AI, Inc. (parent UEI PW4TQZ3KDLU3), a for-profit organization headquartered in Chicago, Illinois, with Ambry operations and laboratory services performed in Laguna Beach, California. The vendor's federal work centers on NAICS 621511 (Medical Laboratories) and PSC reference laboratory testing, representing 63 of 67 recent awards in that category combination.
Ambry's customer base concentrates heavily in the Department of Veterans Affairs, which represents 28 awards (42% of recent awards) split across Veterans Integrated Service Network 17 ($2.5 million combined potential value, 12 awards) and Veterans Integrated Service Network 22 ($1.5 million, 16 awards). The Department of the Army Medical Command accounts for 9 awards valued at $1.5 million. These three customers constitute 75% of award count and 90% of combined potential value. Ambry holds a Blanket Purchase Agreement with VISN 22 (VA26214A0166) with 17 task orders valued at $952 thousand, and a single-award Indefinite Delivery Contract with VISN 17 (36C25721D0067, ceiling $2.09 million, extended through March 2026) carrying 5 prior task orders. A concurrent single-award IDIQ awarded to VISN 17 on March 29, 2026, carries a $72 thousand ceiling through March 28, 2031, with an immediate delivery order for $12,429 issued the same day for the South Texas Veterans Healthcare System. Ambry also maintains a $950 thousand Blanket Purchase Agreement with the Army Medical Command (W81K0215A0027) with 5 task orders.
Recent prime awards include a $2.09 million IDIQ with VISN 17 for specialized genetic reference laboratory testing (whole genome sequencing, cancer predisposition panels, and variant confirmation), delivery orders ranging from $12,319 to $15,828 with completion dates between 2023 and 2027, and a $950 thousand Blanket Purchase Agreement with Army Medical Command for genetic testing services at Tripler Army Medical Center. Activity has grown modestly, increasing from one award per year in 2022–2023 to four awards in both 2025 and 2026. Only one award (combined potential value $12 thousand) reaches ultimate completion within the next twenty-four months, limiting near-term recompete exposure. In its sub-recipient role, Ambry performs research-use-only long-read whole genome sequencing and whole transcriptome sequencing under five federal grant sub-awards from University of California Irvine (awarded December 2025, January 2026, February 2026, July 2025, and May 2024) supporting the GREGoR Consortium for rare disease genomic research, with Ambry providing sample verification, subject recruitment through its clinical exome patient population, and end-to-end assay verification on PacBio Revio and Illumina NovaSeq platforms over three-year performance periods.
Quick answers
Is Ambry Genetics Corporation registered in SAM.gov?
Yes. Ambry Genetics Corporation's SAM.gov registration is active through January 24, 2027.
What is Ambry Genetics Corporation's CAGE code?
Ambry Genetics Corporation's CAGE code is 515T2, and its Unique Entity ID (UEI) is E1VBXEM76NC5.
How much has Ambry Genetics Corporation received in federal contracts?
Federal contracts obligated $16,050 to Ambry Genetics Corporation in fiscal year 2025.
How does Ambry Genetics Corporation rank among federal contractors?
Ambry Genetics Corporation's parent company, Tempus AI, Inc., ranked #12 in NAICS 621511, #14 in NAICS 6215 and #16 in PSC Q3 in FY2025.
What is Ambry Genetics Corporation's most recent federal award?
Ambry Genetics Corporation's most recent federal contract award is South texas veterans healthcare system specialized genetic testing services (36C25726N0266), from Veterans Integrated Service Network 17 (VHA), on March 29, 2026.
On GovTribe
See Ambry Genetics Corporation's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors